483 related articles for article (PubMed ID: 34319550)
1. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
3. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
Jiang Y; Bash LD; Saager L
Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
[TBL] [Abstract][Full Text] [Related]
4. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain.
Martinez-Ubieto J; Aragón-Benedí C; de Pedro J; Cea-Calvo L; Morell A; Jiang Y; Cedillo S; Ramírez-Boix P; Pascual-Bellosta AM
BMC Anesthesiol; 2021 Feb; 21(1):55. PubMed ID: 33593283
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
[TBL] [Abstract][Full Text] [Related]
8. Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial.
Mraovic B; Timko NJ; Choma TJ
Croat Med J; 2021 Dec; 62(6):606-613. PubMed ID: 34981693
[TBL] [Abstract][Full Text] [Related]
9. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
[TBL] [Abstract][Full Text] [Related]
11. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
Wu X; Oerding H; Liu J; Vanacker B; Yao S; Dahl V; Xiong L; Claudius C; Yue Y; Huang Y; Abels E; Rietbergen H; Woo T
BMC Anesthesiol; 2014; 14():53. PubMed ID: 25187755
[TBL] [Abstract][Full Text] [Related]
12. Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients.
Hunt ME; Yates JR; Vega H; Heidel RE; Buehler JM
Ann Pharmacother; 2020 Dec; 54(12):1165-1174. PubMed ID: 32468846
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
Kheterpal S; Vaughn MT; Dubovoy TZ; Shah NJ; Bash LD; Colquhoun DA; Shanks AM; Mathis MR; Soto RG; Bardia A; Bartels K; McCormick PJ; Schonberger RB; Saager L
Anesthesiology; 2020 Jun; 132(6):1371-1381. PubMed ID: 32282427
[TBL] [Abstract][Full Text] [Related]
14. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
Oh MW; Mohapatra SG; Pak T; Hermawan A; Chen CA; Thota B; Chen J; Siu E; Park J; Moon TS
Anesth Analg; 2024 May; 138(5):1043-1051. PubMed ID: 38190344
[TBL] [Abstract][Full Text] [Related]
15. Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
Palsen S; Wu A; Beutler SS; Gimlich R; Yang HK; Urman RD
J Clin Monit Comput; 2019 Jun; 33(3):455-462. PubMed ID: 30094585
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children.
Gaver RS; Brenn BR; Gartley A; Donahue BS
Anesth Analg; 2019 Oct; 129(4):1124-1129. PubMed ID: 31584918
[TBL] [Abstract][Full Text] [Related]
17. The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.
Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Garzon-Siatoya WT; Renew JR; Hernandez-Torres V; Volcheck GW
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):466-473.e5. PubMed ID: 36108924
[TBL] [Abstract][Full Text] [Related]
18. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
19. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
